( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1743.03
1456.68
1539.25
1417.51
Total Expenditure
249.39
237.34
204.67
264.46
PBIDT (Excl OI)
1493.64
1219.34
1334.58
1153.05
Other Income
221.37
373.97
293.43
424.28
Operating Profit
1715
1593.31
1628.01
1577.34
Exceptional Items
NA
NA
NA
NA
PBDT
1708.51
1588.1
1622.68
1571.54
Depreciation
61.28
60.47
56.95
54.46
Profit Before Tax
1647.23
1527.63
1565.73
1517.08
Tax
393.64
378.31
377.52
376.94
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
1253.59
1149.32
1188.21
1140.14
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
1253.59
1149.32
1188.21
1140.14
Minority Interest
NA
NA
NA
NA
Shares of Associates
44.14
41.73
45.26
66.83
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
1297.73
1191.05
1233.47
1206.97
Equity Capital
890.9
890.9
890.9
890.9
Calculated EPS
1.45
1.33
1.38
1.35
Calculated EPS (Annualised)
5.82
5.34
5.53
5.41
No of Public Share Holdings
891692735
891692735
891692735
891692735
% of Public Share Holdings
100
100
100
100
PBIDTM% (Excl OI)
85.69
83.70
86.70
81.34
PBIDTM%
98.39
109.37
105.76
111.27
PBDTM%
98.01
109.02
105.42
110.86
PBTM%
94.50
104.87
101.72
107.02
PATM%
71.92
78.89
77.19
80.43